About the dataset

Primary description: ADNI extension with DoD veterans cohort

The Alzheimer’s Disease Neuroimaging Initiative – Department of Defense is a study funded by the Department of Defense to examine if Traumatic Brain Injury (TBI) and posttraumatic stress disorder (PTSD) contribute to or cause Alzheimer’s Disease. The study recruits Vietnam Veterans with a positive history of either TBI or PTSD. This is assessed through the evaluation of amyloid PET, CSF Aβ and tau data.
Study Alzheimer’s Disease Neuroimaging Initiative - Department of Defense
Study Website ADNI-DOD
Data Descriptor Paper https://pmc.ncbi.nlm.nih.gov/articles/PMC5526098/
DUA https://ncrad.iu.edu/access-samples/available-samples/dod-adni
Country/Region USA
Disease Tag alzheimers
Age (mean ± SD)
(Baseline) 		69.8 ± 4.6
Age Range
(Baseline) 		50-90
% Female 0.7
CUBIC Project /cbica/projects/ADNI
PI for CUBIC Access Approval Christos Davatzikos
N Subjects 275
N MR Sessions 537
Diagnoses
AD
Value V01 V02 V03 V04 V05 V06 V07
other 273 176 17 7 1
nan 8 30 16 4 3 2
DLMUSE (v1.0.7)
(537/537 complete)
/cbica/projects/ADNI/Pipelines/ADNI-DOD_DLMUSE_2025/Results/DLMUSE_Volumes.csv
RAVENS (DRAMMS-1.4.1)
(537/537 complete)
/cbica/projects/ADNI/Pipelines/ADNI-DOD_3.5D_DLICV_MASK_2023/Protocols/RAVENS
Non-Imaging Data
/cbica/projects/ISTAGING/Pipelines/ClinicalDataConsolidation_201911/Data/External_Data/ADNI-DOD

Raw data downloaded from source.

https://adni.loni.usc.edu/data-samples/data-dictionary-search/

Data dictionary of raw data downloaded from source.

/cbica/projects/ISTAGING/Pipelines/ISTAGING_Data_Consolidation_2020/v2.0/istaging.csv

Data consolidated and harmonized in 2020.

This study: subset with df[df.Study == 'ADNI_DOD']

README: /cbica/projects/ISTAGING/Pipelines/ISTAGING_Data_Consolidation_2020/v2.0/README.md

Release Notes: /cbica/projects/ISTAGING/Pipelines/ISTAGING_Data_Consolidation_2020/v2.0/Release_Notes.md

/cbica/home/harmang/for_others/final_combined_istaging_withMUSE.csv

Data consolidated and harmonized in 2026.

This study: subset with df[df.Study == 'ADNI_DOD']


Funding
ADNI (National Institutes of Health Grant U01 AG024904, U01 AG072177) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012) are funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. MESA is supported by contracts 75N92020D00001, HHSN268201500003I, N01-HC-95159, 75N92020D00005, N01-HC-95160, 75N92020D00002, N01-HC-95161, 75N92020D00003, N01-HC-95162, 75N92020D00006, N01-HC-95163, 75N92020D00004, N01-HC-95164, 75N92020D00007, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute, and by grants UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420 from the National Center for Advancing Translational Sciences (NCATS). Brain MRI is supported by grant R01 HL127659 from the National Heart, Lung, and Blood Institute with additional support from the National Institute on Aging and grant R01 AG080821.